PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression ; volume:19 ; number:1 ; day:17 ; month:1 ; year:2017 ; pages:1-14 ; date:12.2017
Breast cancer research ; 19, Heft 1 (17.1.2017), 1-14, 12.2017

Keyword: Krebs
Onkologie

Creator: Shah, Vandna

Contributor: Nowinski, Salpie
Levi, Dina
Shinomiya, Irek
Kebaier Ep Chaabouni, Narda
Gillett, Cheryl
Grigoriadis, Anita
Graham, Trevor A.
Roylance, Rebecca
Simpson, Michael A.
Pinder, Sarah E.
Sawyer, Elinor J.
SpringerLink (Online service)

DOI: 10.1186/s13058-016-0789-y

URN: urn:nbn:de:1111-201702134955

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Shah, Vandna
Nowinski, Salpie
Levi, Dina
Shinomiya, Irek
Kebaier Ep Chaabouni, Narda
Gillett, Cheryl
Grigoriadis, Anita
Graham, Trevor A.
Roylance, Rebecca
Simpson, Michael A.
Pinder, Sarah E.
Sawyer, Elinor J.
SpringerLink (Online service)

Other Objects (12)

PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations

PIK3CA mutations in endocrine-resistant breast cancer

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

ESR1 mutations in metastatic lobular breast cancer patients

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations

PIK3CA mutations in endocrine-resistant breast cancer

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

ESR1 mutations in metastatic lobular breast cancer patients

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations

PIK3CA mutations in endocrine-resistant breast cancer

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

ESR1 mutations in metastatic lobular breast cancer patients

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations

PIK3CA mutations in endocrine-resistant breast cancer

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

ESR1 mutations in metastatic lobular breast cancer patients

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations

PIK3CA mutations in endocrine-resistant breast cancer

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

ESR1 mutations in metastatic lobular breast cancer patients

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations

PIK3CA mutations in endocrine-resistant breast cancer

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

ESR1 mutations in metastatic lobular breast cancer patients

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

Related objects

Reset password